2023
DOI: 10.1016/j.fbio.2023.102374
|View full text |Cite
|
Sign up to set email alerts
|

Screening, ACE-inhibitory mechanism and structure-activity relationship of a novel ACE-inhibitory peptide from Lepidium meyenii (Maca) protein hydrolysate

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
14
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 18 publications
(21 citation statements)
references
References 44 publications
0
14
0
Order By: Relevance
“…PEAKS Studio8.5 was used to analyze the raw MS files, and 359 peptides were identified. The traditional bioactive peptide screening method is time-consuming and laborious [ 27 ]. Hence, bioinformatics is used to replace traditional methods for rapid screening of peptides.…”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations
“…PEAKS Studio8.5 was used to analyze the raw MS files, and 359 peptides were identified. The traditional bioactive peptide screening method is time-consuming and laborious [ 27 ]. Hence, bioinformatics is used to replace traditional methods for rapid screening of peptides.…”
Section: Resultsmentioning
confidence: 99%
“…In the silicon analysis based on the PeptideRanker database, in order to reduce false negatives and obtain as many potential bioactive peptides as possible, we set the score screening threshold to 0.5; that is, peptides with a score higher than 0.5 are considered to have potential biological activity [ 27 ]. A total of 17 peptides meet the requirements.…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…To evaluate the biological activities of the identified peptides, both Peptide Ranker (http://distilldeep.ucd.ie/PeptideRanker/) and the "Profiles of potential biological activity" tab in BIOPEP-UWM can be subsequently used (Lin et al, 2023;Tian et al, 2022). In addition, ADMETlab can be used to systematically predict the in vivo pharmacokinetic properties (including absorption, distribution, metabolism, excretion, and toxicity) of the active peptides, providing evaluations that are especially conducive to the preliminary screening of the peptides ( Dong et al, 2018;Lin et al, 2023). By combining the above bioinformatics tools, it is possible to greatly reduce the complexity of the workflow required for screening ACE inhibitory peptides.…”
Section: Introductionmentioning
confidence: 99%